Cite
HARVARD Citation
Lubeck, D. et al. (2016). Quality adjusted life year gains associated with administration of recombinant tissue-type plasminogen activator for treatment of acute ischemic stroke: 1998–2011. International journal of stroke. 11 (2), pp. 198-205. [Online].